Extracellular matrix gene expression correlates to left ventricular mass index after surgical induction of left ventricular hypertrophy

Basic Research in Cardiology

Volumn 96, Issue 4, 2001, Pages 381-387

  Schubert, A ^a   Walther, T ^a   Falk, V ^a   Binner, C ^a   Loscher N ^a   Kanev, A ^a   Bleiziffer, S ^a   Rauch, T ^a   Autschbach, R ^a   Mohr, F W ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Extracellular matrix; Left ventricular hypertrophy; MMP gene expression; TIMP gene expression

Indexed keywords

MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; CLONING; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ISOLATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART VENTRICLE REMODELING; NONHUMAN; SHEEP; SURGICAL TECHNIQUE;

ANIMALS; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HYPERTROPHY, LEFT VENTRICULAR; MATRIX METALLOPROTEINASES; MYOCARDIUM; PROTEIN ISOFORMS; RNA, MESSENGER; SHEEP; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0034927321     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950170046     Document Type: Article

References (23)

1. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice
2. Matrix metalloproteinase inhibition during the development of congestive heart failure. Effects on left ventricular dimensions and function
3. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method
4. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement
5. Physiologic or pathologic hypertrophy
6. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham heart study
7. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study
8. Clinical significance of left ventricular hypertrophy: Insights from the Framingham study
9. Iatrogenic models for studying heart disease
10. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: Effects of angiotensin converting enzyme inhibition
11. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure
12. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy
13. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription
14. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP3)
15. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter
16. Extracellular matrix dynamics in heart failure: A prospect for gene therapy
17. Time-dependent changes in matrix metalloproteinase - Activity and expression during progression of congestive heart failure. Relation to ventricular and myocyte function
18. Extracellular matrix gene expression in the left ventricular tissue of spontaneously hypertensive rats
19. Molecular and cellular biology of cardiac hypertrophy and failure
20. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth
21. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
22. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis
23. Mechanism of IL-1 induced inhibition of protein synthesis in skeletal muscle